Predictive medicine is an emerging field that has not yet come within
the province of practicing physicians. However, it has been present in
the collective unconscious since time immemorial. Staying in good hea
lth by anticipating the development of diseases and thus initiating op
timal therapy is probably a first priority for many individuals. This
approach requires the development of tools for measuring the risks of
disease. Pedigrees and gene maps are commonly used for this purpose, f
or instance in families afflicted by Down's syndrome or Duchenne's mus
cular dystrophy. HLA-B27 and factor 5 may hold promise for risk evalua
tion. Emphasis should be put, not on the prediction of future disease,
but rather on risk behavior modification and availability of treatmen
ts capable of modifying the natural history of the disease. For some d
iseases, failure to detect the risk would have devastating social and
economic consequences. At the other end of the spectrum, risk evaluati
on has no impact in diseases for which no useful management strategy i
s available. From a social and economic viewpoint, predictive medicine
can be either beneficial or harmful.